Bandingkan Harga & Kinerja Fimperkasa Utama Tbk. (FIMP) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Fimperkasa Utama Tbk. dan UBC Medical Indonesia Tbk.: Fimperkasa Utama Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 27,6 M), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 25× kapitalisasi pasar Fimperkasa Utama Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FIMP | LABS | |
|---|---|---|
Kapitalisasi Pasar | 27,6 M | 691,25 M |
Volume | — | 635,5 rb |
Lot | — | 6,36 rb |
Perputaran | — | 110,15 jt |
Harga Rata-rata | — | 173,33 |
Nilai Transaksi | — | 110,15 jt |
Harga Ekuilibrium Indikatif | — | 174 |
Volume Ekuilibrium Indikatif | — | 50 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Fimperkasa Utama Tbk.
PT Fimperkasa Utama Tbk (the "Company”) established in Indonesia based on Notarial Deed No. 41 of Adam Kasdarmadji, S.H., on February 08, 1993. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Mohamad Mulky Thalib,
Selengkapnya di halaman FIMP →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
